Baird Financial Group’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-19,204
Closed -$175K 1839
2022
Q1
$175K Buy
19,204
+7,827
+69% +$71.3K ﹤0.01% 1762
2021
Q4
$233K Sell
11,377
-135
-1% -$2.77K ﹤0.01% 1772
2021
Q3
$294K Buy
+11,512
New +$294K ﹤0.01% 1673